Cited by 126Virus-based gene therapy researchRNA Interference and Gene DeliveryCRISPR and Genetic Engineering

Gene targeting with viral vectors

Open access
Hendrie, Paul C., Russell, David W.·2005·Molecular Therapy

Abstract

Genetic manipulation of cells for scientific and therapeutic goals can be achieved by both gene-addition and gene-targeting methods. Gene targeting precisely alters a gene in its natural chromosome location, providing distinct advantages over gene-addition approaches. Classic gene-targeting delivery systems (microinjection, electroporation, or calcium phosphate transfection) have led to major scientific advances, but are too inefficient in their current state to be used for some applications, including gene therapy. This review describes the development of gene-targeting vectors based on three types of viruses (retrovirus, adenovirus, and adeno-associated virus) and discusses the design, possible mechanisms of action, and applications of gene-targeting vectors based on adeno-associated virus.

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2005.04.006

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AAV vectors are ideal for performing gene repair due to their ability to target multiple different genomic loci, low immunogenicity, capability to achieve targeted and stable expression through integration, and low mutagenic and oncogenic potential.

    “Adeno-associated virus (AAV) vectors are ideal for performing gene repair due to their ability to target multiple different genomic loci, low immunogenicity, capability to achieve targeted and stable expression through integration, and low mutagenic and oncogenic potential.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hendrie, P. C., & Russell, D. W.
Affiliations
University of Washington (US)
Corresponding author
Russell, David W.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2005-07
Volume
12
Issue
1
Pages
9-17
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2003655346
Cited by
126
References
60
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 2 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 5 · 2015: 7 · 2014: 8 · 2012: 9
FWCI
1.66
Type
journal article
Language
en
Open access
Locations
  • Molecular Therapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
gene targeting, viral vectors, adeno-associated virus, retroviral vectors, adenoviral vector, gene therapy, gene delivery, vector design, transfection efficiency
MeSH terms
Dependovirus, Adenoviridae, Genetic Vectors, Retroviridae, Gene Targeting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review